NCT02607423 2023-05-25
Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Eastern Cooperative Oncology Group
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT02059889 2016-12-16
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
Virginia Commonwealth University
Phase NA Withdrawn
NCT01314677 2012-06-29
Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation
City of Hope Medical Center
Phase NA Withdrawn